SL Science Holding Limite... (SLBT)
NasdaqGM: SLBT
· Real-Time Price · USD
2.67
-0.16 (-5.65%)
At close: Aug 11, 2026, 3:57 PM
2.77
+3.75%
Pre-market: 7:23 AM
SL Science Holding Limited (SLBT) Stock Price, Analysis & Data
-5.65% (1D)
| Bid | 3.16 |
| Market Cap | 1.5B |
| Revenue (ttm) | 3.27M |
| Net Income (ttm) | -2.37M |
| Beta | n/a |
| EPS (ttm) | -0.01 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 2.07 |
| P/S (ttm) | 457.85 |
| Earnings Date | n/a |
| Ask | 4 |
| Volume | 45,878 |
| Avg. Volume (20D) | 746,656 |
| Open | 2.85 |
| Previous Close | 2.83 |
| Day's Range | 2.66 - 2.85 |
| 52-Week Range | 2.54 - 14.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SLBT
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its nam...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 5, 2025
Employees 14
Stock Exchange NasdaqGM
Ticker Symbol SLBT
Website https://www.sl-bio.com
Financial Performance
In 2025, SL Science's revenue was 2.2M, a decrease of -34.68% compared to the previous year's 3.36M. Earnings were -3.82M, an increase of 220.63%.
Financial Statements